• What is a Clinical Trial?
• Phases of Research
• How to Get Involved
• Currently Enrolling Studies
• Phase I: CPU
• Phase II-IV: Main Research
• Phase II-IV: West Side
• Privacy Statement
• FAQ's
• Research Participation Survey

Phase II-IV: Main Research

ID #: 615121 : Renal: Oral medication to determine the effect of rosuvastatin and atorvastatin on urinary protein excretion in diabetic patients.

	Study Medication:		Oral Pill
	Inclusion Criteria:		Males and Females;  Between the age of 18 and 70 years; Type I and II Diabetes
	Study Length:		52 weeks
	Compensation:		$500.00

ID #: 615130 : Weightloss: To assess the safety and efficacy of study drug in overweight and obese patients with Type 2 Diabetes

	Study Medication:		Oral Pill
	Inclusion Criteria:		Type II Diabetes;  Males and females ages 18 to 65 years; must be on oral medication
	Study Length:		63 weeks/17 visits
	Compensation:		$670.00

ID #: 615137 : Cholesterol: Non-diabetic, evaluation of oral medication

	Study Medication:		Oral Pill
	Inclusion Criteria:		Males and Females;  Age 18-70
	Study Length:		17-21 weeks/11 visits
	Compensation:		$900.00

ID #315143:  Diabetes Type 1: To describe changes in insulin requirements and blood glucose levels after treatment

	Study Medication:		Insulin
	Inclusion Criteria:		Type I Diabetes;  Male or Female; 18-44 years old; Must be on insulin
	Study Length:		49 visits
	Compensation:		$3,400.00